Brief: Ovid Therapeutics Q4 EPS USD -0.22 Vs. IBES Estimate USD -0.05
08/03/2024 13:00
Mar 08 (Reuters) - Ovid Therapeutics Q4 basic EPS USD -0.22
Recent news on Ovid Therapeutics
See all newsOvid Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Ovid Therapeutics Q2 revenue beats estimates
Brief: Ovid Therapeutics Q2 EPS USD -0.08
Ovid Therapeutics Inc. expected to post a loss of 11 cents a share - Earnings Preview
Brief: Ovid Therapeutics Appoints Leading Physician-Scientist And Biotech Innovator Anna Greka, M.D., Ph.D., To Board Of Directors